Advances in studies on pharmacological action of main chemical constituent of Curcuma Zedoary in preventing in-stent restenosis.
- Author:
Yuan-yuan CUI
;
Jian-gang LIU
;
Fu-hai ZHAO
;
Da-zhuo SHI
- Publication Type:Journal Article
- MeSH:
Animals;
Constriction, Pathologic;
drug therapy;
prevention & control;
surgery;
Curcuma;
chemistry;
Drugs, Chinese Herbal;
chemistry;
pharmacology;
Endothelium, Vascular;
drug effects;
Humans;
Stents
- From:
China Journal of Chinese Materia Medica
2015;40(7):1230-1234
- CountryChina
- Language:Chinese
-
Abstract:
Traditional Chinese medicine Curcuma Zedoary ( E'Zhu) contains essential oil, curcuminoid and other effective constituents, with such pharmacological actions as anti-platelet aggregation, lowing blood lipid, anti-oxidation and anti-inflammation. In recent years, studies have showed that certain extracts and chemical components of E'Zhu could mitigate myocardial cell mitochondria injury and protect vascular endothelium by enhancing heme oxygenase-1 activity, inhibit nuclear factor NF-kappaB, target genes interleukin-associated kinase-1 (IRAK-1), tumor necrosis factor receptor-6 (TRAF-6) and vascular cell adhesion molecule-1 (VCAM-1), reduce inflammatory infiltration, and inhibit growth factor-induced smooth muscle cells (SMCs) proliferation and migration by impacting oxidation of cellular phosphatases. Due to its different functions in vascular endothelial cells and smooth muscle cells, E'Zhu has been applied in drug-eluting stents, with a potential effect in preventing in-stent restenosis and thrombogenesis. In this paper, studies on pharmacological effects and mechanisms of extracts and main chemical constituents from E'Zhu in preventing vascular restenosis were summarized.
